Radiation Oncology (Jun 2021)
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
- Xiao Chang,
- Wei Deng,
- Xin Wang,
- Zongmei Zhou,
- Jun Yang,
- Wenling Guo,
- Miaoling Liu,
- Xiaolu Qi,
- Ling Li,
- Kaixian Zhang,
- Min Zhang,
- Yonggang Shi,
- Ke Liu,
- Yidian Zhao,
- Huitao Wang,
- Zhilong Yu,
- Jihong Zhang,
- Lihua Wang,
- Xueying Qiao,
- Chun Han,
- Shuchai Zhu,
- Ruohui Zhang,
- Junqiang Chen,
- Cairong Hu,
- Fuquan Zhang,
- Xiaorong Hou,
- Qingsong Pang,
- Wencheng Zhang,
- Gaofeng Li,
- Hailei Lin,
- Xinchen Sun,
- Xiaolin Ge,
- Caihong Li,
- Hong Ge,
- Dingjie Li,
- Yadi Wang,
- Na Lu,
- Xianshu Gao,
- Shangbin Qin,
- Yuan Tian,
- Zefen Xiao
Affiliations
- Xiao Chang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- Wei Deng
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- Xin Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- Zongmei Zhou
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- Jun Yang
- Department of Oncology, First Affiliated Hospital of Xinxiang Medical University
- Wenling Guo
- Department of Oncology, First Affiliated Hospital of Xinxiang Medical University
- Miaoling Liu
- Department of Radiation Oncology, Affiliated Hospital of Hebei University
- Xiaolu Qi
- Department of Radiation Oncology, Affiliated Hospital of Hebei University
- Ling Li
- Department of Oncology, Tengzhou Central People’s Hospital
- Kaixian Zhang
- Department of Oncology, Tengzhou Central People’s Hospital
- Min Zhang
- Department of Oncology, Tengzhou Central People’s Hospital
- Yonggang Shi
- Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Henan Cancer Hospital
- Ke Liu
- Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Henan Cancer Hospital
- Yidian Zhao
- Department of Radiation Oncology, Anyang Tumor Hospital, The Fourth Affiliated Hospital of Henan University of Science and Technology
- Huitao Wang
- Department of Radiation Oncology, Anyang Tumor Hospital, The Fourth Affiliated Hospital of Henan University of Science and Technology
- Zhilong Yu
- Department of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University
- Jihong Zhang
- Department of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University
- Lihua Wang
- Department of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University
- Xueying Qiao
- Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University
- Chun Han
- Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University
- Shuchai Zhu
- Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University
- Ruohui Zhang
- Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University
- Junqiang Chen
- Department of Radiation Oncology, Fujian Cancer Hospital/Fujian Medical University Cancer Hospital
- Cairong Hu
- Department of Radiation Oncology, Fujian Cancer Hospital/Fujian Medical University Cancer Hospital
- Fuquan Zhang
- Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- Xiaorong Hou
- Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- Qingsong Pang
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer
- Wencheng Zhang
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer
- Gaofeng Li
- Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology
- Hailei Lin
- Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology
- Xinchen Sun
- Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University
- Xiaolin Ge
- Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University
- Caihong Li
- Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University
- Hong Ge
- Department of Radiation Oncology, Affiliated Cancer Hospital of Zhengzhou University
- Dingjie Li
- Department of Radiation Oncology, Affiliated Cancer Hospital of Zhengzhou University
- Yadi Wang
- Department of Radiation Oncology, The Seventh Medical Center of PLA General Hospital
- Na Lu
- Department of Radiation Oncology, The Seventh Medical Center of PLA General Hospital
- Xianshu Gao
- Department of Radiation Oncology, Peking University First Hospital, Peking University
- Shangbin Qin
- Department of Radiation Oncology, Peking University First Hospital, Peking University
- Yuan Tian
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- Zefen Xiao
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- DOI
- https://doi.org/10.1186/s13014-020-01691-4
- Journal volume & issue
-
Vol. 16,
no. 1
pp. 1 – 8
Abstract
Abstract Purpose To investigate the interobserver variability (IOV) in target volume delineation of definitive radiotherapy for thoracic esophageal cancer (TEC) among cancer centers in China, and ultimately improve contouring consistency as much as possible to lay the foundation for multi-center prospective studies. Methods Sixteen cancer centers throughout China participated in this study. In Phase 1, three suitable cases with upper, middle, and lower TEC were chosen, and participants were asked to contour a group of gross tumor volume (GTV-T), nodal gross tumor volume (GTV-N) and clinical target volume (CTV) for each case based on their routine experience. In Phase 2, the same clinicians were instructed to follow a contouring protocol to re-contour another group of target volume. The variation of the target volume was analyzed and quantified using dice similarity coefficient (DSC). Results Sixteen clinicians provided routine volumes, whereas ten provided both routine and protocol volumes for each case. The IOV of routine GTV-N was the most striking in all cases, with the smallest DSC of 0.37 (95% CI 0.32–0.42), followed by CTV, whereas GTV-T showed high consistency. After following the protocol, the smallest DSC of GTV-N was improved to 0.64 (95% CI 0.45–0.83, P = 0.005) but the DSC of GTV-T and CTV remained constant in most cases. Conclusion Variability in target volume delineation was observed, but it could be significantly reduced and controlled using mandatory interventions.
Keywords